Skip to content
← Full study record

NCT01159067 · OUTCOME

Number of Patients With Serum Ferritin Level Lower Than 1500 ng/mL After Treatment

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · Source last updated 2019-06-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Assessed through 6 months from the start of treatment

What was measured

Number of patients, whose Serum Ferritin levels are lower than 1500 ng/mL at two consecutive study visits. Serum Ferritin levels are measured at screening (baseline), week 4, 8, 12, 16, 20, 24 and end of study.

Groups in this outcome

Arm I

Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I1

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    units
    Participants
description
Number of patients, whose Serum Ferritin levels are lower than 1500 ng/mL at two consecutive study visits. Serum Ferritin levels are measured at screening (baseline), week 4, 8, 12, 16, 20, 24 and end of study.
groups
  1. description
    Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.
    id
    OG000
    title
    Arm I
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Assessed through 6 months from the start of treatment
title
Number of Patients With Serum Ferritin Level Lower Than 1500 ng/mL After Treatment
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice